Protara Therapeutics, Inc.: accounts_payable
| Value | {"amount": 4031000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2026-03-31) |
| Status | current |
| Entity | Protara Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T12:59:58.519146+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/b7f3e5b2-7280-47b5-be26-60a52df69f2a
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-26-055463 · Open the official SEC filing →Retrieved: 2026-08-19T12:59:58.519146+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001359931/accounts-payable/2026-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/b7f3e5b2-7280-47b5-be26-60a52df69f2a
History
- no predecessors — first report